2021 Virtual ESMO Review


 

ESMO 2021 Highlights on Stage III NSCLC and Malignant Mesothelioma: PORT Efficacy in Lung ART, PACIFIC-R Study, and CheckMate 743

54 views
November 5, 2021
0 Comments
Login to view comments. Click here to Login